CPT-1 deficiency is a AR disorder characterized by an increased risk of hypoglycemia, liver failure, hepatic encephalopathy and hyperammonaemia, particularly during periods of fasting or illness (73). This evidence concerns the gene CPT1A and hyperinsulinemic hypoglycemia, familial, 4.